Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19909215 | 0.93 | ALDH1A1 (0.33) | KDM4EALDH1A1HPGDHSD17B10 | |
| SCHEMBL19909210 | 0.88 | METAP2 (0.33) | KDM4EALDH1A1HPGDHSD17B10 | |
| SCHEMBL22563683 | 0.87 | ALDH1A1 (0.33) | KDM4EALDH1A1HPGDHSD17B10 | |
| SCHEMBL19943081 | 0.87 | PDE9A (0.34) | KDM4EALDH1A1HPGDHSD17B10 | |
| SCHEMBL19909216 | 0.85 | ALDH1A1 (0.38) | KDM4EALDH1A1HPGDHSD17B10 | |
| SCHEMBL21278713 | 0.84 | ALDH1A1 (0.32) | KDM4EALDH1A1HPGDHSD17B10 | |
| SCHEMBL21414246 | 0.84 | CYP1A2 (0.35) | KDM4EALDH1A1HPGDHSD17B10 | |
| SCHEMBL19909486 | 0.83 | SQOR (0.35) | ALDH1A1HPGD | |
| SCHEMBL19943082 | 0.83 | L3MBTL1 (0.41) | KDM4EALDH1A1HPGDHSD17B10 | |
| SCHEMBL24656014 | 0.82 | L3MBTL1 (0.36) | KDM4EALDH1A1HPGDHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11588114-B2 | Organic molecules for use in optoelectronic devices | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-02-21 | — | — | US | disclosed |
| US-20200212316-A1 | ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES | CYNORA GMBH (DE) | 2020-07-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200212316-A1 | ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES | OR10J3, OPRM1, OR51E2 | KDM4E 4526/4885ALDH1A1 297/4885HPGD 2205/4885 |
| US-11588114-B2 | Organic molecules for use in optoelectronic devices | OR10J3, OPRM1, OR51E2 | KDM4E 4526/4885ALDH1A1 297/4885HPGD 2205/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.